Dabigatran etexilate

Details

Files

Generic Name:

Project Status:

Cancelled

Therapeutic Area:

Atrial fibrillation prevention of stroke and systemic embolism

Manufacturer:

Boehringer-Ingelheim (Canada) Ltd.

Call for patient/clinician input open:

June 4, 2010

Brand Name:

Pradaxa

Project Line:

Reimbursement Review

Project Number:

SR0202-000

Call for patient/clinician input closed:

June 25, 2010

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Atrial fibrillation prevention of stroke and systemic embolism

Last Updated : May 31, 2010